These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11599616)

  • 1. Citalopram distribution in postmortem cases.
    Levine B; Zhang X; Smialek JE; Kunsman GW; Frontz ME
    J Anal Toxicol; 2001 Oct; 25(7):641-4. PubMed ID: 11599616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of citalopram in biological specimens from postmortem cases.
    Jenkins AJ; Gubanich K
    J Forensic Sci; 2002 Jan; 47(1):159-64. PubMed ID: 12064644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYD2D6 and CYP2C19.
    Holmgren P; Carlsson B; Zackrisson AL; Lindblom B; Dahl ML; Scordo MG; Druid H; Ahlner J
    J Anal Toxicol; 2004 Mar; 28(2):94-104. PubMed ID: 15068562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual multiple drug intoxication case involving citalopram.
    Fu K; Konrad RJ; Hardy RW; Brissie RM; Robinson CA
    J Anal Toxicol; 2000 Oct; 24(7):648-50. PubMed ID: 11043674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmortem concentrations of citalopram.
    Anastos N; McIntyre IM; Lynch MJ; Drummer OH
    J Forensic Sci; 2002 Jul; 47(4):882-4. PubMed ID: 12137000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in rats.
    Kugelberg FC; Druid H; Carlsson B; Ahlner J; Bengtsson F
    J Anal Toxicol; 2004; 28(8):631-7. PubMed ID: 15538956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-phase postmortem redistribution of the enantiomers of citalopram and its demethylated metabolites in rats.
    Kugelberg FC; Kingbäck M; Carlsson B; Druid H
    J Anal Toxicol; 2005; 29(4):223-8. PubMed ID: 15975250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.
    Brøsen K; Naranjo CA
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):275-83. PubMed ID: 11532381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic drug-drug interaction study between raltegravir and citalopram.
    Blonk MI; Langemeijer CC; Colbers AP; Hoogtanders KE; van Schaik RH; Schouwenberg BJ; Burger DM
    Antivir Ther; 2016; 21(2):143-52. PubMed ID: 26375942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study.
    Berzas-Nevado JJ; Villaseñor-Llerena MJ; Guiberteau-Cabanillas C; Rodríguez-Robledo V
    Electrophoresis; 2006 Feb; 27(4):905-17. PubMed ID: 16470634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness/ruggedness study.
    Berzas Nevado JJ; Villaseñor Llerena MJ; Guiberteau Cabanillas C; Rodríguez Robledo V
    J Chromatogr A; 2006 Aug; 1123(1):130-3. PubMed ID: 16814307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta.
    Heikkine T; Ekblad U; Laine K
    BJOG; 2002 Sep; 109(9):1003-8. PubMed ID: 12269673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy exposure to citalopram - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood.
    Paulzen M; Goecke TW; Stingl JC; Janssen G; Stickeler E; Gründer G; Schoretsanitis G
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):213-219. PubMed ID: 28663113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects.
    Møller SE; Larsen F; Khant AZ; Rolan PE
    J Clin Psychopharmacol; 2001 Oct; 21(5):493-9. PubMed ID: 11593075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.
    Kasper S; Sacher J; Klein N; Mossaheb N; Attarbaschi-Steiner T; Lanzenberger R; Spindelegger C; Asenbaum S; Holik A; Dudczak R
    Int Clin Psychopharmacol; 2009 May; 24(3):119-25. PubMed ID: 19367152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.
    von Moltke LL; Greenblatt DJ; Grassi JM; Granda BW; Venkatakrishnan K; Duan SX; Fogelman SM; Harmatz JS; Shader RI
    Biol Psychiatry; 1999 Sep; 46(6):839-49. PubMed ID: 10494454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of selective serotonin reuptake inhibitors.
    Hiemke C; Härtter S
    Pharmacol Ther; 2000 Jan; 85(1):11-28. PubMed ID: 10674711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of a single dose of ketoconazole on the pharmacokinetics of citalopram.
    Gutierrez M; Abramowitz W
    Pharmacotherapy; 2001 Feb; 21(2):163-8. PubMed ID: 11213852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations.
    Kosel M; Gnerre C; Voirol P; Amey M; Rochat B; Bouras C; Testa B; Baumann P
    Mol Psychiatry; 2002; 7(2):181-8. PubMed ID: 11840311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.